Cyberonics Expects VNS Will Capture 4% Of U.S. Depression Market By 2010
Cyberonics anticipates FDA approval of a depression indication for its VNS Therapy vagus nerve stimulation system by October 2004
Cyberonics anticipates FDA approval of a depression indication for its VNS Therapy vagus nerve stimulation system by October 2004